跳至主要内容
临床试验/NCT00976235
NCT00976235已完成不适用

Five Year Follow up of IMT-002 Patients; A Long-Term Monitoring Study of IMT-002 Patients

VisionCare, Inc.55 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
129
试验地点
55
主要终点
Long term safety (Intraocular pressure, Slit lamp, Endothelial Cell Density, Visual Acuity, Complications, Adverse Events and Device Failures)

研究概览

简要总结

This is a 5-year study of patients implanted with the Implantable Miniature Telescope (IMT by Dr. Isaac Lipshitz) under Protocol IMT-002. All patients implanted with the telescope prosthesis who enrolled in the IMT-002 trial were asked to participate in this study to monitor long-term safety. Patients will undergo examinations at six-month intervals up to a total of 5 years following implantation.

详细描述

Every 6 months, manifest refraction, visual acuity, intraocular pressure, slit lamp examination, endothelial cell density, device failures, complications and adverse events will be assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have participated in the IMT-002 trial.
  • Patients must be able to understand and comply with the requirements of the clinical study, and be able to abide by the requirements and restrictions of the study.
  • Patients must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form.

排除标准

  • Patients who have not participated in the IMT-002 trial.

结局指标

主要结局

Long term safety (Intraocular pressure, Slit lamp, Endothelial Cell Density, Visual Acuity, Complications, Adverse Events and Device Failures)

时间窗: 5 years from implantation

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (55)

Loading locations...

相似试验

A Long-Term Monitoring Study of the IMT-002 Patients | 临床试验